PubMed RSS Feed - -Topical timolol in dermatology: infantile hemangiomas and beyond

[rss]

Clin Exp Dermatol. 2021 Nov 19. doi: 10.1111/ced.15021. Online ahead of print.

ABSTRACT

Timolol, a non-selective β-adrenergic receptor blocker, is well-tolerated and is becoming increasingly popular in dermatology especially after its use in the management of infantile hemangiomas. Its effects are mainly due to vasoconstriction, inhibition of angiogenesis and keratinocyte migration promotion for re-epithelialization and wound healing. We review the evidence behind the use of timolol in several dermatological conditions including infantile hemangiomas, pyogenic granulomas, Kaposi's sarcoma, chronic wound healing, post-surgical wounds, acne vulgaris, rosacea, eczema and red scrotum syndrome.

PMID:34798680 | DOI:10.1111/ced.15021

{url} = URL to article